Thyroid Cancer Assessment
Thyroid cancer assessment evaluates suspicious thyroid nodules and confirmed cancers — determining type, stage, and appropriate treatment pathway.
Early specialist evaluation improves outcomes for all thyroid cancer types.
Last medically reviewed: 1 November 2025
Diagnostic workup
Suspicious nodules undergo ultrasound risk stratification and FNAC. Confirmed cancers require staging — neck ultrasound for lymph nodes, and for medullary cancer, calcitonin and RET genetic testing.
Anaplastic cancer requires urgent biopsy and multidisciplinary evaluation.
Treatment planning
Treatment depends on cancer type and stage: surgery (lobectomy or total thyroidectomy), selective radioactive iodine for differentiated cancers, hormone suppression, and targeted therapies for advanced disease.
A personalised plan is developed with surgical and oncology input as needed.
Second opinions
Patients diagnosed elsewhere can seek review of biopsy results, staging, and treatment recommendations — particularly valuable before committing to surgery.
Frequently asked questions
How quickly should suspected cancer be evaluated?
Promptly — thyroid cancers are usually not emergencies, but delays allow growth. Most can be evaluated within days to weeks.
Do I need genetic testing?
Medullary thyroid cancer requires RET genetic testing. Other types may warrant genetic evaluation if there is a strong family history.
What is the prognosis?
Differentiated thyroid cancers (papillary, follicular) have excellent long-term survival. Medullary and anaplastic cancers have more variable outcomes — early specialist care is critical.
References & further reading
This page is based on established medical knowledge and guidelines from authoritative sources. Always consult a qualified clinician for personal medical advice.
Ready to discuss your thyroid health?
Book a specialist consultation — in person or by teleconsultation.